Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding
424,966,351
Total 13F shares
155,310,287
Share change
+9,163,533
Total reported value
$6,522,638,173
Put/Call ratio
141%
Price per share
$42.07
Number of holders
129
Value change
+$367,540,942
Number of buys
93
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
11%
46,015,330
$2,234,044,000 30 Jun 2020
13F
FMR LLC
13F
Company
3.8%
16,356,491
$743,419,000 30 Jun 2020
13F
HARVARD MANAGEMENT CO INC
13F
Company
3.5%
14,690,780
$713,237,000 30 Jun 2020
13F
Capital International Investors
13F
Company
1.9%
8,137,055
$395,054,000 30 Jun 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.9%
8,022,471
$389,491,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
1.5%
6,205,186
$301,261,000 30 Jun 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.3%
5,605,531
$272,148,000 30 Jun 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.1%
4,507,138
$218,822,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.88%
3,723,924
$180,797,000 30 Jun 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.77%
3,251,110
$157,842,000 30 Jun 2020
13F
VIKING GLOBAL INVESTORS LP
13F
Company
0.59%
2,514,985
$122,103,000 30 Jun 2020
13F
NORGES BANK
13F
Company
0.54%
2,302,508
$111,787,000 30 Jun 2020
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
0.51%
2,153,000
$104,528,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
0.48%
2,050,145
$99,534,000 30 Jun 2020
13F
GENERAL ATLANTIC, L.P.
13F
Individual
0.35%
1,500,000
$72,825,000 30 Jun 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.34%
1,425,370
$69,201,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
0.33%
1,383,360
$67,162,000 30 Jun 2020
13F
Bleichroeder LP
13F
Company
0.26%
1,115,980
$54,181,000 30 Jun 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.28%
1,200,000
$51,684,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.22%
923,605
$44,841,000 30 Jun 2020
13F
HealthCor Management, L.P.
13F
Company
0.22%
916,350
$44,489,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
830,274
$40,309,000 30 Jun 2020
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.18%
762,579
$37,023,000 30 Jun 2020
13F
TimesSquare Capital Management, LLC
13F
Company
0.18%
750,800
$36,451,000 30 Jun 2020
13F
Artal Group S.A.
13F
Company
0.18%
750,000
$36,413,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
0.18%
750,000
$36,413,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.17%
721,802
$35,043,000 30 Jun 2020
13F
Capital International, Inc./CA/
13F
Company
0.13%
562,600
$27,314,000 30 Jun 2020
13F
Rock Springs Capital Management LP
13F
Company
0.12%
500,000
$24,275,000 30 Jun 2020
13F
EATON VANCE MANAGEMENT
13F
Company
0.1%
441,851
$21,452,000 30 Jun 2020
13F
Alyeska Investment Group, L.P.
13F
Company
0.1%
435,195
$21,129,000 30 Jun 2020
13F
SAMLYN CAPITAL, LLC
13F
Company
0.1%
426,000
$20,682,000 30 Jun 2020
13F
Brown University
13F
Company
0.09%
381,759
$18,534,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.09%
366,330
$17,786,000 30 Jun 2020
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.07%
300,000
$14,565,000 30 Jun 2020
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.06%
275,000
$13,351,000 30 Jun 2020
13F
Avidity Partners Management LP
13F
Company
0.05%
200,000
$9,710,000 30 Jun 2020
13F
Redmile Group, LLC
13F
Company
0.05%
200,000
$9,710,000 30 Jun 2020
13F
Squarepoint Ops LLC
13F
Company
0.05%
200,000
$9,710,000 30 Jun 2020
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.05%
216,145
$9,489,000 30 Jun 2020
13F
TD ASSET MANAGEMENT INC
13F
Company
0.04%
188,891
$9,171,000 30 Jun 2020
13F
Zimmer Partners, LP
13F
Company
0.04%
181,500
$8,812,000 30 Jun 2020
13F
Monashee Investment Management LLC
13F
Company
0.04%
180,000
$8,739,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
161,667
$7,849,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.04%
158,876
$7,713,000 30 Jun 2020
13F
Islet Management, LP
13F
Company
0.04%
150,000
$7,283,000 30 Jun 2020
13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.03%
122,349
$5,940,000 30 Jun 2020
13F
Atika Capital Management LLC
13F
Company
0.03%
117,000
$5,681,000 30 Jun 2020
13F
CRAMER ROSENTHAL MCGLYNN LLC
13F
Company
0.02%
100,000
$4,855,000 30 Jun 2020
13F
Iron Triangle Partners LP
13F
Company
0.02%
100,000
$4,855,000 30 Jun 2020
13F

Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q3 2020

As of 30 Sep 2020, Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,310,287 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, HARVARD MANAGEMENT CO INC, Capital International Investors, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, and BlackRock Inc.. This page lists 129 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
119
Q3 2020 holders
129
Holder diff
10
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .